Crispr Therapeutics AG Strategic Asset Allocation Index
Crispr Therapeutics AG strategic asset allocation index. Crispr Therapeutics AG (CRSP) has a Strategic Asset Allocation Index of 1.5% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $28.41 Million) total $28.41 Million, measured against net assets of $1.92 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check CRSP tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Crispr Therapeutics AG (2016–2024)
Strategic asset allocation index of Crispr Therapeutics AG from 2016 to 2024. This chart shows how Crispr Therapeutics AG's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 1.5%, representing strategic assets of $28.41 Million against net assets of $1.92 Billion USD.
Crispr Therapeutics AG Strategic Asset Allocation Index by Year (2016–2024)
Crispr Therapeutics AG strategic asset allocation index by year from 2016 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Crispr Therapeutics AG from 2016 to 2024, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Crispr Therapeutics AG market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $1.93 Billion | ▼ -0.1 pp |
| 2023 | 0.1% | $1.97 Million | $- | $1.97 Million | $1.88 Billion | ▼ -11.5 pp |
| 2022 | 11.6% | $216.76 Million | $163.63 Million | $53.13 Million | $1.88 Billion | ▲ +5.8 pp |
| 2021 | 5.7% | $137.57 Million | $137.57 Million | $0.00 | $2.40 Billion | ▲ +3.2 pp |
| 2020 | 2.5% | $42.16 Million | $42.16 Million | $- | $1.66 Billion | ▼ -5.2 pp |
| 2019 | 7.8% | $72.83 Million | $72.83 Million | $- | $939.42 Million | ▲ +3.0 pp |
| 2018 | 4.7% | $18.50 Million | $18.50 Million | $- | $392.19 Million | ▼ -5.3 pp |
| 2017 | 10.0% | $18.86 Million | $18.86 Million | $- | $187.83 Million | ▲ +1.0 pp |
| 2016 | 9.0% | $21.03 Million | $21.03 Million | $- | $232.85 Million | — |